MarketPeel
Insider Trading Intelligence
GH

Gwenn Hansen

NRIX
CHIEF SCIENTIFIC OFFICER · NURIX THERAPEUTICS, INC. · CIK 0001817160
FILING MIX · LIFETIME43%/57%
BUYS
72
SELLS
96
TOTAL VALUE
$1.23M
COMPANIES
1
ACTIVE SINCE
Nov 2020
HOLDINGS NOW
115,005
AVG SELL PX
$18.44
TRADE KIND
SHOWING 168 / 168
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
36 backtested trades · 8 horizons · 19 pending
Forward-return performance of every backtestable P/S trade by Gwenn Hansen, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d36+52.78%-3.38%+0.14%-3.52%-2.48%-1.77
14d36+69.44%-3.65%+0.92%-4.57%-4.34%-2.11
30d36+63.89%-3.68%+1.37%-5.32%-6.70%-1.73
60d36+69.44%-2.26%+1.98%-4.25%-12.64%-0.83
90d36(1 pending)+62.86%-7.40%+3.54%-10.94%-12.50%-2.28
180d36(3 pending)+69.70%-8.46%+5.94%-14.39%-27.01%-1.65
1y36(5 pending)+83.87%-19.79%+7.32%-27.10%-46.62%-2.05
2y36(10 pending)+65.38%-27.82%+17.41%-45.23%-74.32%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NRIX · 115,005 shares · as of Jun 25, 2026
037,50075,000112,500150,000202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 72 buys / 96 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
NRIX
NURIX THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,394$20.00$107.9K115,005Jun 25, 2026Jun 25, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,0000Apr 30, 2026Apr 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,750120,755Apr 30, 2026Apr 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
2,000117,005Apr 30, 2026Apr 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,214$16.65$53.5K120,399Apr 30, 2026Apr 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
2,858123,613Apr 30, 2026Apr 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,75015,000Apr 30, 2026Apr 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,85822,867Apr 30, 2026Apr 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
93,75093,750Feb 10, 2026Feb 10, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
42,87542,875Feb 10, 2026Feb 10, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
31,3330Feb 3, 2026Feb 3, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
31,333$0.84$26.3K115,005Feb 3, 2026Feb 3, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
2,85988,567Jan 30, 2026Jan 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,75018,750Jan 30, 2026Jan 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,0002,000Jan 30, 2026Jan 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,75085,708Jan 30, 2026Jan 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
4,797$16.58$79.5K83,770Jan 30, 2026Jan 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,85925,725Jan 30, 2026Jan 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
98$17.37$1.7K83,672Jan 30, 2026Jan 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,20779,958Jan 30, 2026Jan 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,2070Jan 30, 2026Jan 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
2,00081,958Jan 30, 2026Jan 30, 2026View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,2073,207Oct 30, 2025Oct 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,20772,230Oct 30, 2025Oct 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
2,85880,838Oct 30, 2025Oct 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,75022,500Oct 30, 2025Oct 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,0004,000Oct 30, 2025Oct 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,75077,980Oct 30, 2025Oct 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
2,00074,230Oct 30, 2025Oct 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
4,087$12.80$52.3K76,751Oct 30, 2025Oct 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,85828,584Oct 30, 2025Oct 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,00020,000Oct 14, 2025Oct 23, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,2076,414Jul 30, 2025Jul 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,75026,250Jul 30, 2025Jul 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,0006,000Jul 30, 2025Jul 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,20764,723Jul 30, 2025Jul 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,85831,442Jul 30, 2025Jul 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
2,00066,723Jul 30, 2025Jul 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,75070,473Jul 30, 2025Jul 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
2,85873,331Jul 30, 2025Jul 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
4,308$12.01$51.7K69,023Jul 30, 2025Jul 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,2069,621Apr 30, 2025Apr 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,377$11.50$38.8K61,516Apr 30, 2025Apr 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,20659,143Apr 30, 2025Apr 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
2,00061,143Apr 30, 2025Apr 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,75030,000Apr 30, 2025Apr 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,0008,000Apr 30, 2025Apr 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,75064,893Apr 30, 2025Apr 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
34,30034,300Feb 11, 2025Feb 13, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
75,00075,000Feb 11, 2025Feb 13, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,75059,627Jan 30, 2025Jan 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,00010,000Jan 30, 2025Jan 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,75033,750Jan 30, 2025Jan 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
2,00055,877Jan 30, 2025Jan 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,20712,827Jan 30, 2025Jan 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
333$20.33$6.8K55,937Jan 30, 2025Jan 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,20753,877Jan 30, 2025Jan 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,357$19.81$66.5K56,270Jan 30, 2025Jan 30, 2025View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,00012,000Oct 30, 2024Oct 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,75037,500Oct 30, 2024Oct 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
2,00050,357Oct 30, 2024Oct 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,75054,107Oct 30, 2024Oct 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,20716,034Oct 30, 2024Oct 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,437$24.31$83.5K50,670Oct 30, 2024Oct 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,20748,357Oct 30, 2024Oct 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
2,00044,808Jul 30, 2024Jul 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,00014,000Jul 30, 2024Jul 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,75048,558Jul 30, 2024Jul 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,75041,250Jul 30, 2024Jul 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,20742,808Jul 30, 2024Jul 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,20719,241Jul 30, 2024Jul 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,408$20.67$70.4K45,150Jul 30, 2024Jul 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
2,00041,608Apr 30, 2024Apr 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,00016,000Apr 30, 2024Apr 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,20639,608Apr 30, 2024Apr 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,007$12.04$24.2K39,601Apr 30, 2024Apr 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,20622,448Apr 30, 2024Apr 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
45,00045,000Feb 13, 2024Feb 15, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
150,000150,000Feb 13, 2024Feb 15, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,334$7.99$18.6K36,402Jan 30, 2024Jan 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,20736,736Jan 30, 2024Jan 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,20725,654Jan 30, 2024Jan 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
2,00038,736Jan 30, 2024Jan 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,00018,000Jan 30, 2024Jan 30, 2024View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,633$5.20$8.5K33,529Oct 31, 2023Nov 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
2,00035,162Oct 30, 2023Nov 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,20728,861Oct 30, 2023Nov 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,20733,162Oct 30, 2023Nov 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,00020,000Oct 30, 2023Nov 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,884$9.65$18.2K29,955Jul 31, 2023Aug 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,20732,068Jul 30, 2023Aug 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
2,00031,839Jul 30, 2023Aug 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
2,00022,000Jul 30, 2023Aug 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,20729,839Jul 30, 2023Aug 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,136$9.88$11.2K26,632May 1, 2023May 2, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,20627,768Apr 30, 2023May 2, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,20635,275Apr 30, 2023May 2, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
24,00024,000Feb 14, 2023Feb 15, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
88,90088,900Feb 14, 2023Feb 15, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,20724,421Jan 30, 2023Feb 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,20738,481Jan 30, 2023Feb 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,412$11.78$16.6K23,009Jan 30, 2023Feb 1, 2023View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,165$12.88$15.0K21,214Oct 31, 2022Nov 1, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,20722,379Oct 30, 2022Nov 1, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,20741,688Oct 30, 2022Nov 1, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
60,29860,298Aug 9, 2022Aug 10, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,186$15.67$18.6K19,172Aug 1, 2022Aug 2, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,20720,358Jul 30, 2022Aug 2, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,20744,895Jul 30, 2022Aug 2, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,098$11.75$12.9K17,151May 2, 2022May 3, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
3,20648,102Apr 30, 2022May 3, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
3,20618,249Apr 30, 2022May 3, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
51,30851,308Jan 19, 2022Jan 21, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
115,438115,438Jan 19, 2022Jan 21, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,42881,905Jan 3, 2022Jan 4, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
40067,466Jan 3, 2022Jan 4, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
400$7.26$2.9K14,597Jan 3, 2022Jan 4, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,828$28.96$52.9K14,197Jan 3, 2022Jan 4, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
1,428$9.57$13.7K16,025Jan 3, 2022Jan 4, 2022View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
400$7.26$2.9K14,597Dec 1, 2021Dec 2, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
400$29.13$11.7K14,197Dec 1, 2021Dec 2, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
40067,866Dec 1, 2021Dec 2, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
400$33.24$13.3K14,197Nov 1, 2021Nov 2, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
40068,266Nov 1, 2021Nov 2, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
400$7.26$2.9K14,597Nov 1, 2021Nov 2, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
400$35.00$14.0K14,197Oct 27, 2021Oct 28, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
40068,666Oct 27, 2021Oct 28, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
400$7.26$2.9K14,597Oct 27, 2021Oct 28, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
400$29.92$12.0K14,197Oct 1, 2021Oct 4, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
40069,066Oct 1, 2021Oct 4, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
400$7.26$2.9K14,597Oct 1, 2021Oct 4, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,60069,466Sep 7, 2021Sep 8, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
1,600$35.00$56.0K14,197Sep 7, 2021Sep 8, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
1,600$7.26$11.6K15,797Sep 7, 2021Sep 8, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
400$32.34$12.9K14,197Sep 1, 2021Sep 2, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
400$7.26$2.9K14,597Sep 1, 2021Sep 2, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
40071,066Sep 1, 2021Sep 2, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
400$31.21$12.5K13,804Aug 2, 2021Aug 3, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
400$7.26$2.9K14,204Aug 2, 2021Aug 3, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
40071,466Aug 2, 2021Aug 3, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
400$7.26$2.9K14,204Jul 1, 2021Jul 2, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
40071,866Jul 1, 2021Jul 2, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
400$26.76$10.7K13,804Jul 1, 2021Jul 2, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
400$27.74$11.1K13,804Jun 1, 2021Jun 2, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
40072,266Jun 1, 2021Jun 2, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
400$7.26$2.9K14,204Jun 1, 2021Jun 2, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
80072,666May 3, 2021May 4, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
800$35.00$28.0K13,804May 3, 2021May 4, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
800$7.26$5.8K14,604May 3, 2021May 4, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
400$35.00$14.0K13,804Apr 5, 2021Apr 6, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
40073,466Apr 5, 2021Apr 6, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
400$7.26$2.9K14,204Apr 5, 2021Apr 6, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
400$31.55$12.6K13,804Apr 1, 2021Apr 2, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
400$7.26$2.9K14,204Apr 1, 2021Apr 2, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
40073,866Apr 1, 2021Apr 2, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
80074,266Mar 16, 2021Mar 16, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
800$45.00$36.0K13,804Mar 16, 2021Mar 16, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
800$7.26$5.8K14,604Mar 16, 2021Mar 16, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
80075,066Mar 1, 2021Mar 2, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
800$35.95$28.8K13,804Mar 1, 2021Mar 2, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
800$7.26$5.8K14,604Mar 1, 2021Mar 2, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
800$7.26$5.8K12,800Feb 18, 2021Feb 22, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
200$37.67$7.5K12,000Feb 18, 2021Feb 22, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
80075,866Feb 18, 2021Feb 22, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
600$35.81$21.5K12,200Feb 18, 2021Feb 22, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
60,00060,000Feb 11, 2021Feb 12, 2021View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
Chief Scientific Officer
12,00031,333Nov 30, 2020Dec 1, 2020View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
Chief Scientific Officer
12,000$0.84$10.1K12,000Nov 30, 2020Dec 1, 2020View →
Other insiders · NRIX
Loading peer insiders…
About this filer
CIK 0001817160
ROLE
Chief Scientific Officer
PRIMARY
NRIX
COMPANIES
1
ACTIVE SINCE
Nov 2020
MARKETPEEL · /INSIDER/0001817160DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback